Open AccessThe results of open observational trial DIAMOND
Author(s) -
Marina Shestakova,
Шестакова Марина Владимировна,
Ольга Константиновна Викулова,
Викулова Ольга Константиновна
Publication year - 2011
Publication title -
saharnyj diabet
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 12
eISSN - 2072-0378
pISSN - 2072-0351
DOI - 10.14341/2072-0351-6232
Subject(s) - medicine , gliclazide , observational study , diabetes mellitus , randomized controlled trial , surgery , endocrinology
Aim. DIAMOND (DIAMicrON in Daily practice) is an open non-randomized observational trial aimed to estimate the efficacy and safety of gliclazide(Diamicron MB) in routine clinical practice. Materials and methods. 394 patients with poor control of type 2 diabetes mellitus (T2 DM), previously treated with diet or one of oral antidiabeticdrug (OAD), were switched to Diamicron MB. Previous therapy was left unchanged, except for a sulfonylurea or glinide that were canceled. Results. After 6 months of Diamicron MB therapy (30% monotherapy, 70% combined therapy) target HbA1c